/

Società

AS

Società

ASABYS

Di cosa scriviamo

Auto/AutomotiveIngegneriaSaluteSanitàUniversità

24 comunicati stampa

Guarda tutti i comunicati

Press Release cover image

17/11/2025

Salute

Sanità

Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn’s Disease - Asabys Partners

Fonte

1.00

0

Press Release cover image

04/11/2025

Economia

Economia internazionale

Salute

Sport

Qida raises €37 million to continue improving the quality of life of the senior segment at home - Asabys Partners

Fonte

1.00

0

Press Release cover image

14/10/2025

Salute

Oncologia

Sanità

Ona Therapeutics, a portfolio company of Asabys Partners and Alta Life Sciences, appoints Dr. Antoine Yver as Chair of the Board to accelerate its ADC programs towards clinical development - Asabys Partners

Fonte

1.00

0

Press Release cover image

10/09/2025

Salute

Sanità

Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financing to Accelerate Commercialization of Colovac® - Asabys Partners

Fonte

1.00

0

Press Release cover image

11/06/2025

Salute

Sanità

SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines - Asabys Partners

Fonte

1.00

0

Press Release cover image

29/04/2025

Università

Salute

Sanità

Deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection - Asabys Partners

Fonte

1.00

0

Press Release cover image

17/04/2025

Università

Salute

Sanità

Three Asabys-Backed Biotechs Featured in Nature, Showcasing Spain’s Scientific Innovation - Asabys Partners

Fonte

1.00

0

01/04/2025

Università

Salute

Sanità

Nuage Therapeutics appoints Dr. Stuart Hughes as CEO and Vanessa Malier as Chair - Asabys Partners

Fonte

1.00

0

24/03/2025

Università

Salute

Sanità

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round - Asabys Partners

Fonte

1.00

0

28/01/2025

Salute

Sanità

Quibim Announces $50 Million in Series A Financing, led by Asabys and Buenavista, to Revolutionize Precision Medicine with AI-Powered Imaging Biomarkers - Asabys Partners

Fonte

1.00

0

Seguaci

0

Compatibilità

0